A practical nomogram and risk stratification system predicting the cancer‐specific survival for patients with early hepatocellular carcinoma
Authors:
Open Access
- 6 December 2020
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 10 (2) , 496-506
Abstract
Background: Our purpose was to establish and validate a nomogram model in early hepatocellular carcinoma (HCC) patients for predicting the cancer‐specific survival (CSS).Methods: We extracted eligible data of relevant patients between 2010 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database. Further, we divided all patients into two groups (training and validation cohorts) at random (7:3). Nomogram was established using effective risk factors based on univariate and multivariate analysis. The effective performance of nomogram was evaluated using concordance index (C‐index), calibration plots, decision curve analysis (DCA), and receiver operating characteristic curve (ROC).Results: We selected 3620 patients with early HCC including the training cohort (70%, 2536) and the validation cohort (30%, 1084). The nomogram‐related C‐indexes were 0.755 (95% CI: 0.739–0.771) and 0.737 (95% CI: 0.712–0.762), in the training and validation cohorts, respectively. The calibration plots showed good consistency of 3‐and 5‐year CSS between the actual observation and the nomogram prediction. The 3‐, 5‐year DCA curves also indicated that the nomogram has excellent clinical utility. The 3‐, 5‐year area under curve (AUC) of ROC in the training cohort were 0.783, 0.779, respectively, and 0.767, 0.766 in the validation cohort, respectively. With the establishment of nomogram, a risk stratification system was also established that could divide all patients into three risk groups, and the CSS in different groups (i.e., low risk, intermediate risk, and high risk) had a good regional division.Conclusions: We developed a practical nomogram in early HCC patients for predicting the CSS, and a risk stratification system follow arisen, which provided an applicable tool for clinical management.Keywords
This publication has 33 references indexed in Scilit:
- Surgical Therapy for Early Hepatocellular Carcinoma in the Modern EraAnnals of Surgery, 2013
- External validation of a simplified BCLC staging system for early hepatocellular carcinomaEuropean Journal of Surgical Oncology, 2013
- Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinomaEuropean Journal of Cancer, 2011
- Comparative performances of staging systems for early hepatocellular carcinomaHPB, 2009
- Predictors of Survival After Resection of Early Hepatocellular CarcinomaAnnals of Surgery, 2009
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Diagnosis and Treatment of Hepatocellular CarcinomaGastroenterology, 2008
- Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or lessGut, 2005
- Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective studyJournal of Hepatology, 2005
- Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging systemCancer, 2002